School of Materials Science and Engineering, Beijing Institute of Technology, Beijing 100081, People's Republic of China.
School of Life Science, Beijing Institute of Technology, Beijing 100081, People's Republic of China.
Biomed Mater. 2021 Feb 24;16(2):022009. doi: 10.1088/1748-605X/abd2c8.
Extracellular vesicles (EVs) are cell secretory native components with long-circulation, good biocompatibility, and physiologic barriers cross ability. EVs derived from different donor cells inherit varying characteristics and functions from their original cells and are favorable to serve as vectors for diagnosing and treating various diseases. However, EVs nanotheranostics are still in their infancy because of their limited accumulation at lesion sites and compromised therapy efficiency. Hence, engineering modification of EVs is usually needed to further enhance their stability, biological activity, and lesion-targeting capacity. Herein, we overview the characteristics of EVs from different sources, as well as the latest developments of surface engineering and cargo loading methods. We also focus especially on advances in EVs-based disease theranostics. At the end of the review, we predict the obstacles and prospects of the future clinical application of EVs.
细胞外囊泡(EVs)是具有长循环、良好生物相容性和生理屏障穿透能力的细胞分泌天然成分。源自不同供体细胞的 EVs 从其原始细胞继承了不同的特征和功能,有利于作为诊断和治疗各种疾病的载体。然而,由于其在病变部位的有限积累和治疗效率受损,EVs 纳米治疗仍处于起步阶段。因此,通常需要对 EVs 进行工程修饰,以进一步提高其稳定性、生物活性和病变靶向能力。本文综述了不同来源的 EVs 的特性,以及表面工程和载药方法的最新进展。我们还特别关注基于 EVs 的疾病治疗学的进展。在综述的最后,我们预测了 EVs 未来临床应用的障碍和前景。